European Journal of Pharmacology

AMP-activated protein kinase and hypoxic pulmonary vasoconstriction

Robertson, T. P., Mustard, K. J. W., Lewis, T. H., Clark, J. H., Wyatt, C. N., Blanco, E. A., Peers, C., Hardie, D. G. & Evans, A. M. 24-Oct-2008 In : European Journal of Pharmacology. 595, 1-3, p. 39-43, 5 p.

Research output: Contribution to journal › Article

Functional pharmacology of human prostanoid EP2 and EP4 receptors

Wilson, R. J., Rhodes, S. A., Wood, R. L., Shield, V. J., Noel, L. S., Gray, D. W. & Giles, H. 6-Oct-2004 In : European Journal of Pharmacology. 501, 1-3, p. 49-58, 10 p.

Research output: Contribution to journal › Article

Gliclazide: a general free radical scavenger

Scott, N. A., Jennings, P. E., Brown, J. & Belch, J. J. F. 14-Oct-1991 In : European Journal of Pharmacology. 208, 2, p. 175-177, 3 p.

Research output: Contribution to journal › Article

Nitric oxide synthesis inhibitors attenuate calcitonin gene-related peptide endothelium-dependent vasorelaxation in rat aorta

Gray, D. W. & Marshall, I. 1992 In : European Journal of Pharmacology. 212, 1, p. 37-42, 6 p.

Research output: Contribution to journal › Article

The role of bioreductive activation of antitumour anthracycline drugs in cytotoxic activity against sensitive and multidrug resistant leukaemia HL60 cells

Kostrzewa-Nowak, D., Bieg, B., Paine, M. J. I., Wolf, C. R. & Tarasiuk, J. 14-Jan-2012 In : European Journal of Pharmacology. 674, 2-3, p. 112-125, 14 p.

Research output: Contribution to journal › Article